| Name | Company | Title | Industry | Location | Country | |
|---|---|---|---|---|---|---|
| Denise Schultz | dsc*****@bluebirdbio.com | bluebird bio | Director, Regulatory Affairs CMC | Biotechnology Research | Sudbury, MA, US | |
| Emily Swick | esw***@bluebirdbio.com | bluebird bio | Manager, Corporate Communications | Biotechnology Research | Boston, Massachusetts, United States | |
| Frances Smith | fsm***@bluebirdbio.com | bluebird bio | Vice President | Biotechnology Research | Cambridge, MA, US | |
| Karen Schorr | ksc****@bluebirdbio.com | bluebird bio | Chief Compliance Officer | Biotechnology Research | Cambridge, Massachusetts, United States | |
| Eduardo Molina | emo****@bluebirdbio.com | bluebird bio | Vice President Marketing, Strategy and Analytics | Biotechnology Research | Boston, MA, US | |
| Alison Conlon | aco****@bluebirdbio.com | bluebird bio | Vice President, Strategic Planning | Biotechnology Research | Cambridge, MA, US | |
| Jill Ochoa | joc***@bluebirdbio.com | bluebird bio | Director, Quality Systems | Biotechnology Research | Cambridge, MA, US | |
| Kate Haviland | kha******@blueprintmedicines.com | Lengo Therapeutics | Chief Executive Officer | Biotechnology Research | Boston, MA, US | United States |
| Christina Rossi | cro***@blueprintmedicines.com | Lengo Therapeutics | Chief Operating Officer | Biotechnology Research | Somerville, MA, US | United States |
| Fouad Namouni | fna*****@blueprintmedicines.com | Lengo Therapeutics | President, Research & Development | Biotechnology Research | Cambridge, MA, US | United States |